These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 30847938

  • 1. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
    Jia L, Sun P, Gao H, Shen J, Gao Y, Meng C, Fu S, Yao H, Zhang G.
    J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
    [Abstract] [Full Text] [Related]

  • 2. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L, Jiang D, Geng J, Dong R, Dai H.
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [Abstract] [Full Text] [Related]

  • 3. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L, Wang CC, Song XP, Wang HM, Zhou H, Sun Y, Wang XK, Hou S, Pei FY.
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [Abstract] [Full Text] [Related]

  • 4. [Research on ameliorating pulmonary fibrosis in silicosis mice of Cordyceps cicadae polysaccharides].
    Cao L, Wang GL, Chen L, Liu SP.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Sep 20; 42(9):641-649. PubMed ID: 39394701
    [Abstract] [Full Text] [Related]

  • 5. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.
    BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658
    [Abstract] [Full Text] [Related]

  • 6. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H, Lv Z, Liu S, Zhang L, Huang K, Gao S, Gan W, Liu X, Zhang S, Helian K, Li X, Zhou H, Yang C.
    J Pharm Pharmacol; 2020 Jan 02; 72(1):44-55. PubMed ID: 31659758
    [Abstract] [Full Text] [Related]

  • 7. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC, Li DL, Xu L, Mo XT, Cui WH, Zhao P, Zhou WC, Gao J, Li J.
    J Pharmacol Exp Ther; 2015 Sep 02; 354(3):302-9. PubMed ID: 26126535
    [Abstract] [Full Text] [Related]

  • 8. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW, Jia YL, Ge LT, Jiang B, Jiang JX, Shen J, Jin YC, Guan Y, Sun Y, Xie QM.
    Toxicology; 2017 Aug 15; 389():31-41. PubMed ID: 28694203
    [Abstract] [Full Text] [Related]

  • 9. Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis.
    Su X, Liu K, Xie Y, Zhang M, Wu X, Zhang Y, Wang J.
    Biomed Pharmacother; 2021 Jan 15; 133():110919. PubMed ID: 33202282
    [Abstract] [Full Text] [Related]

  • 10. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways.
    Hao W, Yu TT, Zuo DZ, Hu HZ, Zhou PP.
    Exp Lung Res; 2023 Nov 20; 49(1):205-219. PubMed ID: 38044666
    [Abstract] [Full Text] [Related]

  • 11. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH, Li M, Ma HF, Li W, Liu L, Yin Y, Zhou XM, Hou G.
    Life Sci; 2020 Jan 15; 241():117139. PubMed ID: 31809714
    [Abstract] [Full Text] [Related]

  • 12. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.
    Tang F, Gong H, Ke T, Yang W, Yang Y, Liu Z.
    Discov Med; 2024 Aug 15; 36(187):1616-1626. PubMed ID: 39190377
    [Abstract] [Full Text] [Related]

  • 13. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
    Wang Y, Li R, Chen L, Tan W, Sun Z, Xia H, Li B, Yu Y, Gong J, Tang M, Ji Y, Yuan S, Shanglong Yao, Shang Y.
    Shock; 2015 Nov 15; 44(5):496-502. PubMed ID: 26196843
    [Abstract] [Full Text] [Related]

  • 14. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
    Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH.
    Int Immunopharmacol; 2014 Oct 15; 22(2):498-504. PubMed ID: 25111852
    [Abstract] [Full Text] [Related]

  • 15. Urine-Derived Stem Cells Reverse Bleomycin‑Induced Experimental Pulmonary Fibrosis by Inhibition of the TGF-β1-Smad2/3 Pathway.
    Zhang Y, Xia Y, Zhang R, Zhou X, Jiang J.
    Cytotherapy; 2024 Oct 15; 26(10):1236-1244. PubMed ID: 38852093
    [Abstract] [Full Text] [Related]

  • 16. ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways.
    Jia C, Yang M, Xiao G, Zeng Z, Li L, Li Y, Jiang J, Xu A, Qiu J, Tang R, Li D, Jia D, Xie C, Wu G, Cai D, Bi X.
    Phytomedicine; 2024 Sep 15; 132():155545. PubMed ID: 38972238
    [Abstract] [Full Text] [Related]

  • 17. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
    Jin M, Wu Y, Wang L, Zang B, Tan L.
    Phytother Res; 2016 Apr 15; 30(4):577-87. PubMed ID: 26777519
    [Abstract] [Full Text] [Related]

  • 18. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
    Song X, Liu W, Xie S, Wang M, Cao G, Mao C, Lv C.
    Lab Invest; 2013 Nov 15; 93(11):1219-31. PubMed ID: 24042439
    [Abstract] [Full Text] [Related]

  • 19. Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-β1/Smad3/ plasminogen activator inhibitor-1 signaling pathway.
    Wang J, Fang C, Wang S, Fang F, Chu X, Liu N, Lu C, Wang S, Li W.
    J Tradit Chin Med; 2020 Apr 15; 40(2):236-244. PubMed ID: 32242389
    [Abstract] [Full Text] [Related]

  • 20. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R, Wang X, Zhao X, Song N, Zhu J, Wang J, Wang J, Xia C, Chen Y, Zhu D, Shen L.
    Sci Rep; 2016 Oct 24; 6():35696. PubMed ID: 27774992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.